MedTrace Logo

Effects of Core Stability and Pelvic Clock Exercises in Sacroiliac Joint Dysfunction

NCT07440849 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-02-27

No results posted yet for this study

Summary

The study will be a randomized control trial and will be conducted in DHQ and Sadiq Hospital in Sargodha District. This study will be completed in time duration of 10 months after the approval of synopsis. Nonprobability convenience sampling technique will be used and 50 participants will be recruited in study after randomization. The subjects will be divided into two groups. Group A(Experimental) will receive core stability and pelvic clock exercises with baseline treatment while Group B(Control) will receive only core stability exercises after baseline treatment. The tools that will be used are Numeric Pain Rating Scale (NPRS), Oswestry Disability index (ODI) and WHOQOL-BREF. Treatment have duration of 8 weeks with 3 sessions per week and an hour per session is requires. After data collection, data will be analyzed by using SPSS version 26.

Conditions

  • Sacroiliac Joint Dysfunction

Interventions

OTHER

core stability exercises

Core stability exercises were performed in modified or low-impact forms suitable for the postpartum phase to ensure safety for participants with sacroiliac joint dysfunction. Each exercise session included two sets of core stability exercises with ten repetitions per set, performed two to three times per week for a total duration of eight weeks.

OTHER

pelvic clock exercises

Pelvic clock exercises were performed in a hook-lying position to promote spinal alignment and minimize lumbar lordosis. These exercises were designed to improve pelvic awareness, control, and mobility.Pelvic clock exercises were performed for two to three minutes, three times per week, for a duration of eight weeks

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • adeela arif, t-DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-01
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07440849 on ClinicalTrials.gov